To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Morningstar: Roche: Data Confirms Invirase Shows Efficacy In HIV URL: http://www.pslgroup.com/dg/216512.htm Doctor's Guide October 26, 2007
ZURICH, SWITZERLAND -- October, 25, 2007 -- Swiss drugmaker Roche Holding AG said Thursday that final 48 week results from the international 'GEMINI' head-to-head trial, presented at the 11th European AIDS Conference demonstrate that HIV-infected patients treated with the boosted protease inhibitor Invirase 500/r, achieved similar levels of viral suppression and increases in CD4 cells compared to those treated with Kaletra, a commonly used protease inhibitor.